Voglit 0.3mg Tablet
Marketer
Stallion Laboratories Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglit 0.3mg Tablet
Diabetol 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating postprandial hyperglycemia (high blood sugar after meals), particularly when dietary modifications and other similar treatments prove insufficient. Diabetol 0.3mg should be administered immediately before meals. Dosage frequency is determined individually by your physician to optimize blood glucose control. Discontinuing this medication abruptly is strongly discouraged; doing so may lead to elevated blood sugar levels, potentially resulting in severe complications such as renal impairment and vision loss. Successful treatment necessitates a comprehensive approach including a balanced diet, regular physical activity, and weight management as recommended by your doctor. Regular blood glucose monitoring is essential while using Diabetol 0.3mg. Commonly reported side effects include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Persistent or bothersome side effects warrant medical attention. While Diabetol 0.3mg alone does not cause hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) increases this risk. Hypoglycemic episodes should be treated with plain glucose; ordinary table sugar is ineffective in this context. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver conditions. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all current medications is crucial for safe use. Excessive alcohol consumption should be avoided due to the increased hypoglycemia risk.
Primary Ingredients of Voglit 0.3mg Tablet
No text provided to rephrase.
Uses of Voglit 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglit 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Voglit tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Voglit 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglit 0.3mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Voglit tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Voglit 0.3mg Tablet works:
Glucodown 0.3mg tablets are used to manage diabetes. They work by blocking enzymes in the intestines that digest complex carbohydrates, thus moderating postprandial glucose spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglit 0.3mg Tablet and alcohol is not advised due to safety concerns.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Voglit 0.3mg tablets is generally deemed safe. Animal research indicates minimal or no negative impacts on fetal development; nonetheless, human data remains scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglit 0.3mg tablets safely. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglit 0.3mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglit 0.3mg Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.3mg Voglit tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglit 0.3mg Tablet :
Omit any missed Voglit 0.3mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Voglit 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently